189 research outputs found

    MOCDroid: multi-objective evolutionary classifier for Android malware detection

    Get PDF
    Malware threats are growing, while at the same time, concealment strategies are being used to make them undetectable for current commercial Anti-Virus. Android is one of the target architectures where these problems are specially alarming, due to the wide extension of the platform in different everyday devices.The detection is specially relevant for Android markets in order to ensure that all the software they offer is clean, however, obfuscation has proven to be effective at evading the detection process. In this paper we leverage third-party calls to bypass the effects of these concealment strategies, since they cannot be obfuscated. We combine clustering and multi-objective optimisation to generate a classifier based on specific behaviours defined by 3rd party calls groups. The optimiser ensures that these groups are related to malicious or benign behaviours cleaning any non-discriminative pattern. This tool, named MOCDroid, achieves an ac-curacy of 94.6% in test with 2.12% of false positives with real apps extracted from the wild, overcoming all commercial Anti-Virus engines from VirusTotal

    RV-Android: Efficient Parametric Android Runtime Verification, a Brief Tutorial

    Get PDF
    International audienceRV-Android is a new freely available open source runtime library for monitoring formal safety properties on Android. RV-Android uses the commercial RV-Monitor technology as its core monitoring library generation technology, allowing for the verification of safety properties during execution and operating entirely in userspace with no kernel or operating system modifications required. RV-Android improves on previous Android monitoring work by replacing the JavaMOP framework with RV-Monitor, a more advanced monitoring library generation tool with core algorithmic improvements that greatly improve resource consumption , e and battery life considerations. We demonstrate the developer usage of RV-Android with the standard Android build process, using instrumentation mechanisms e↵ective on both Android binaries and source code. Our method allows for both property development and advanced application testing through runtime verification. We showcase the user frontend of RV-Monitor, which is available for public demo use and requires no knowledge of RV concepts. We explore the extra expres-siveness the MOP paradigm provides over simply writing properties as aspects through two sample security properties, and show an example of a real security violation mitigated by RV-Android on-device. Lastly, we propose RV as an extension to the next-generation Android permissions system debuting in Android M

    A Genotype-First Approach for the Molecular and Clinical Characterization of Uncommon De Novo Microdeletion of 20q13.33

    Get PDF
    Background: Subtelomeric deletions of the long arm of chromosome 20 are rare, with only 11 described in the literature. Clinical features of individuals with these microdeletions include severe limb malformations, skeletal abnormalities, growth retardation, developmental and speech delay, mental retardation, seizures and mild, non-specific dysmorphic features. Methodology/Principal Findings: We characterized microdeletions at 20q13.33 in six individuals referred for genetic evaluation of developmental delay, mental retardation, and/or congenital anomalies. A comparison to previously reported cases of 20q13.33 microdeletion shows phenotypic overlap, with clinical features that include mental retardation, developmental delay, speech and language deficits, seizures, and behavior problems such as autistic spectrum disorder. There does not appear to be a clinically recognizable constellation of dysmorphic features among individuals with subtelomeric 20q microdeletions. Conclusions/Significance: Based on genotype-phenotype correlation among individuals in this and previous studies, we discuss several possible candidate genes for specific clinical features, including ARFGAP1, CHRNA4 and KCNQ2 and neurodevelopmental deficits. Deletion of this region may play an important role in cognitive development

    Inflammatory mediators in breast cancer: Coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>The inflammatory chemokines CCL2 (MCP-1) & CCL5 (RANTES) and the inflammatory cytokines TNFα & IL-1β were shown to contribute to breast cancer development and metastasis. In this study, we wished to determine whether there are associations between these factors along stages of breast cancer progression, and to identify the possible implications of these factors to disease course.</p> <p>Methods</p> <p>The expression of CCL2, CCL5, TNFα and IL-1β was determined by immunohistochemistry in patients diagnosed with: (1) Benign breast disorders (=healthy individuals); (2) Ductal Carcinoma <it>In Situ </it>(DCIS); (3) Invasive Ducal Carcinoma without relapse (IDC-no-relapse); (4) IDC-with-relapse. Based on the results obtained, breast tumor cells were stimulated by the inflammatory cytokines, and epithelial-to-mesenchymal transition (EMT) was determined by flow cytometry, confocal analyses and adhesion, migration and invasion experiments.</p> <p>Results</p> <p>CCL2, CCL5, TNFα and IL-1β were expressed at very low incidence in normal breast epithelial cells, but their incidence was significantly elevated in tumor cells of the three groups of cancer patients. Significant associations were found between CCL2 & CCL5 and TNFα & IL-1β in the tumor cells in DCIS and IDC-no-relapse patients. In the IDC-with-relapse group, the expression of CCL2 & CCL5 was accompanied by further elevated incidence of TNFα & IL-1β expression. These results suggest progression-related roles for TNFα and IL-1β in breast cancer, as indeed indicated by the following: (1) Tumors of the IDC-with-relapse group had significantly higher persistence of TNFα and IL-1β compared to tumors of DCIS or IDC-no-relapse; (2) Continuous stimulation of the tumor cells by TNFα (and to some extent IL-1β) has led to EMT in the tumor cells; (3) Combined analyses with relevant clinical parameters suggested that IL-1β acts jointly with other pro-malignancy factors to promote disease relapse.</p> <p>Conclusions</p> <p>Our findings suggest that the coordinated expression of CCL2 & CCL5 and TNFα & IL-1β may be important for disease course, and that TNFα & IL-1β may promote disease relapse. Further <it>in vitro </it>and <it>in vivo </it>studies are needed for determination of the joint powers of the four factors in breast cancer, as well as analyses of their combined targeting in breast cancer.</p

    A comprehensive overview of radioguided surgery using gamma detection probe technology

    Get PDF
    The concept of radioguided surgery, which was first developed some 60 years ago, involves the use of a radiation detection probe system for the intraoperative detection of radionuclides. The use of gamma detection probe technology in radioguided surgery has tremendously expanded and has evolved into what is now considered an established discipline within the practice of surgery, revolutionizing the surgical management of many malignancies, including breast cancer, melanoma, and colorectal cancer, as well as the surgical management of parathyroid disease. The impact of radioguided surgery on the surgical management of cancer patients includes providing vital and real-time information to the surgeon regarding the location and extent of disease, as well as regarding the assessment of surgical resection margins. Additionally, it has allowed the surgeon to minimize the surgical invasiveness of many diagnostic and therapeutic procedures, while still maintaining maximum benefit to the cancer patient. In the current review, we have attempted to comprehensively evaluate the history, technical aspects, and clinical applications of radioguided surgery using gamma detection probe technology
    corecore